Patient Monitoring Devices – Market Insights – United States

The global COVID-19 pandemic positively affected the US market for patient monitoring devices, bolstering unit sales and revenue in 2020. Over the forecast period, increasing sales among ASCs, particularly through rising adoption of novel wireless monitoring technologies—supported by recent changes to CMS reimbursement guidelines—will contribute to market growth. The market will also be driven by favorable demographic trends and growing demand for patient monitoring devices in nonhospital settings, although market saturation and limited innovation in mature patient monitoring device segments will limit the pace of market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for patient monitoring devices in the US from 2019 through 2031.

The COVID-19 pandemic had a positive impact on the overall US patient monitoring device market.

How did the impact of the COVID-19 pandemic differ between device segments?

When will the market return to prepandemic levels?

The patient monitoring device market will be supported by government regulations and technological advancements.

How are these factors driving the market for patient monitoring devices?

Which segments are seeing the strongest growth?

Which device segment represents the largest share of patient monitoring device revenues?

The home care monitoring device market is attracting new players.

Which technological advances are driving the adoption of home care monitoring devices?

What factors will influence the entry of new players in this segment?

How will the established competitors react to heightened competitive pressure?

Efforts to reduce readmission and hospital-acquired infection rates in the US will play a major role in patient monitoring device selection.

How are concerns over readmission penalties and hospital-acquired infections impacting patient monitoring device selection in the US?

To what extent will each market segment be affected by these factors?

What measures are device manufacturers taking to ensure their products remain attractive to US hospitals?

Less invasive methods of patient monitoring will increasingly replace invasive techniques in response to the denial of reimbursement for cases of hospital-acquired infections.

To what extent will each market segment be affected by these shifts in monitoring techniques?

How will the preference for less invasive methods drive product adoption in the patient monitoring device market?

How can established device manufacturers without experience in patient monitoring take advantage of high-growth market segments?

Will innovations in the market cause system prices to fluctuate over the forecast period?

Table of contents